Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors.

作者: Pier Luigi Ferrarini , Vincenzo Calderone , Tiziana Cavallini , Clementina Manera , Giuseppe Saccomanni

DOI: 10.1016/J.BMC.2004.01.035

关键词:

摘要: Cannabinoid receptors have been studied extensively in view of their potential functional role several physiological and pathological processes. For this reason, the search for new potent, selective ligands subtype CB receptors, CB(1) CB(2), is still great importance, order to investigate various functions. The present study describes synthesis biological properties a series 1,8-naphthyridine derivatives, characterised by presence some important structural requirements exhibited other classes cannabinoid ligands, such as an aliphatic or aromatic carboxamide group position 3, alkyl arylalkyl substituent 1. These compounds were assayed binding both brain peripheral (CB(1) CB(2)). results obtained indicate that naphthyridine derivatives examined possess greater affinity CB(2) receptor than receptor. In particular, 6a 7a appreciable receptor, with K(i) values 5.5 8.0 nM respectively; also 4a, 5a 8a exhibit good affinity, range 10-44 nM. Furthermore, 3g-i 18 revealed selectivity, CB(1)/CB(2) ratio >20.

参考文章(20)
A C Howlett, L S Melvin, W A Devane, F A Dysarz, M R Johnson, Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology. ,vol. 34, pp. 605- 613 ,(1988)
Tetsudo Kaya, Hiroyuki Iwamura, Hidekazu Suzuki, Takashi Inaba, Yoshifumi Ueda, In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. Journal of Pharmacology and Experimental Therapeutics. ,vol. 296, pp. 420- 425 ,(2001)
Jean-Mario Mussinu, Stefania Ruiu, Antonio C Mulè, Amedeo Pau, Mauro A.M Carai, Giovanni Loriga, Gabriele Murineddu, Gérard A Pinna, Tricyclic pyrazoles. Part 1: synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1and CB2 cannabinoid receptors. Bioorganic & Medicinal Chemistry. ,vol. 11, pp. 251- 263 ,(2003) , 10.1016/S0968-0896(02)00319-X
William A Devane, Lumir Hanuš, Aviva Breuer, Roger G Pertwee, Lesley A Stevenson, Graeme Griffin, Dan Gibson, Asher Mandelbaum, Alexander Etinger, Raphael Mechoulam, ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR Science. ,vol. 258, pp. 1946- 1949 ,(1992) , 10.1126/SCIENCE.1470919
Lawrence D. Recht, Rebecca Salmonsen, Ronald Rosetti, Tai Jang, George Pipia, Tomacz Kubiatowski, Pusha Karim, Alonzo H. Ross, Robert Zurier, N. Scott Litofsky, Sumner Burstein, Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochemical Pharmacology. ,vol. 62, pp. 755- 763 ,(2001) , 10.1016/S0006-2952(01)00700-6
M. Herkenham, A. B. Lynn, M. D. Little, M. R. Johnson, L. S. Melvin, B. R. de Costa, K. C. Rice, Cannabinoid receptor localization in brain Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 1932- 1936 ,(1990) , 10.1073/PNAS.87.5.1932
Gerald R. Lappin, Cyclization of 2-aminopyridine derivatives; substituted ethyl 2-pyridylamino-methylenemalonates. Journal of the American Chemical Society. ,vol. 70, pp. 3348- 3350 ,(1948) , 10.1021/JA01190A038
Sean Munro, Kerrie L. Thomas, Muna Abu-Shaar, Molecular characterization of a peripheral receptor for cannabinoids Nature. ,vol. 365, pp. 61- 65 ,(1993) , 10.1038/365061A0
Robert B. Zurier, Ronald G. Rossetti, Joan H. Lane, John M. Goldberg, Sheila A. Hunter, Sumner H. Burstein, Dimethylheptyl‐THC‐11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure Arthritis & Rheumatism. ,vol. 41, pp. 163- 170 ,(1998) , 10.1002/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9
Murielle Rinaldi-Carmona, Francis Barth, Michel Héaulme, David Shire, Bernard Calandra, Christian Congy, Serge Martinez, Jeanne Maruani, Gervais Néliat, Daniel Caput, Pascual Ferrara, Philippe Soubrié, Jean Claude Brelière, Gérard Le Fur, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Letters. ,vol. 350, pp. 240- 244 ,(1994) , 10.1016/0014-5793(94)00773-X